Do you think CGS will provide updated earnings guidance now with the approval of aducanumab? Management seems to be very quiet considering they had been really pushing the positive impact approval of aducanumab would have on the company.
Ann: Loan Forgiven re US Governments Paycheck Protection Program, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.74 |
Change
0.080(4.82%) |
Mkt cap ! $295.4M | |||
| Open | High | Low | Value | Volume |
| $1.69 | $1.74 | $1.67 | $27.62K | 16.33K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 10490 | $1.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.75 | 3613 | 2 |
View Market Depth
| Last trade - 16.10pm 14/07/2025 (20 minute delay) ? |
| CGS (ASX) Chart |